Search clinical trials for: Liraglutide

Total 462 results

The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Not yet recruiting

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

Delirium, Postoperative
Seoul National University Hospital

Recruiting

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Craniopharyngioma | Panhypopituitarism | Hypothalamic Obesity

Korea, Republic of
University of Chicago

Not yet recruiting

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Multiple Sclerosis | Obesity | Obesity, Morbid | Obese | Long COVID | Long Covid19 | Acute Leukemia in Remission
Beni-Suef University

Not yet recruiting

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Polycystic Ovary

Egypt
Mỹ Đức Hospital

Not yet recruiting

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Obesity | Polycystic Ovary Syndrome | Infertility, Female
Carmot Therapeutics, Inc.

Recruiting

A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes

Type 1 Diabetes

United States
RenJi Hospital

Recruiting

Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Obesity, Abdominal | Non-Alcoholic Fatty Liver Disease | Metabolism Disorder, Glucose | Metabolism Disorder, Lipid | Metformin | Abdominal Fat

China
Hospital Universitario San Ignacio

Recruiting

Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

Diabetes Mellitus, Type 2 Treated With Insulin

Colombia
Louisiana State University Health Sciences Center...
Tulane University; Pennington Biomedical Research Center; Ochsner Health System

Recruiting

Anti-obesity Pharmacotherapy and Inflammation

Obesity

United States
Emirates Health Services (EHS)

Recruiting

POSE2.0 With GLP-1 Agonist for Obesity Management

Obesity

United Arab Emirates
Columbia University

Recruiting

Effects of GH and Lirglutide on AgRP

Healthy | Growth Hormone Deficiency

United States
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality (Desire PLUS)

Sexual Desire

Switzerland
The Affiliated Nanjing Drum Tower Hospital of Nanjing...
Nanjing First Hospital, Nanjing Medical University; Wuxi People's Hospital; Changzhou... and other collaborators

Recruiting

Effects of Liraglutide, Empagliflozin and Linagliptin on the Cognitive Function in T2DM Patients With Mild Cognitive Impairment: a Multicenter, Randomized, Parallel Controlled Clinical Trial

Type 2 Diabetes Mellitus | Mild Cognitive Impairment

China
General Committee of Teaching Hospitals and Institutes...

Not yet recruiting

Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.

Morbid Obesity

Egypt
Mansoura University

Recruiting

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Obesity

Egypt
Biolingus
Chinese University of Hong Kong

Recruiting

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Diabete Type 2

Hong Kong
University Hospital Birmingham
University of Birmingham

Recruiting

Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF ) (GOAL-AF)

Recurrence | Atrial Fibrillation | Overweight and Obesity | Liraglutide

United Kingdom
Lawson Health Research Institute
Seagen Inc.

Recruiting

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Diffuse Cutaneous Systemic Sclerosis

Canada
Kaiser Permanente
Patient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaborators

Recruiting

Comparison of Type 2 Diabetes Pharmacotherapy Regimens (ON TARGET DM)

Cardiovascular Diseases | Type 2 Diabetes Mellitus

United States
Fred Hutchinson Cancer Center
Medexus Pharma, Inc.

Recruiting

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
American University of Beirut Medical Center

Recruiting

The Effect of Different Diets on Arterial Stiffness in Obese Patients on Liraglutide

Obesity | Weight Loss

Lebanon
University of Campania "Luigi Vanvitelli"

Recruiting

Liraglutide and Peripheral Artery Disease (STARDUST)

Peripheral Arterial Disease | Type 2 Diabetes

Italy
Zhejiang Provincial People's Hospital
Ningbo Medical Center Lihuili Hospital; Red Cross Hospital, Hangzhou, China; The... and other collaborators

Not yet recruiting

Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Type 2 Diabetes Mellitus | Liraglutide | Arteriosclerotic Cardiovascular Disease
National and Kapodistrian University of Athens
Athens Medical Center

Recruiting

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

Obesity | Blood Pressure

Greece
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Recruiting

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome (ZQL008)

Metabolic Syndrome

United States
University Health Network, Toronto

Recruiting

Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial (NATRIURETIC)

Type 2 Diabetes Mellitus

Canada
Marmara University

Recruiting

Life Style Modification Medical and Surgical Management in Patients With Obesity

Obesity | Obesity, Metabolically Benign | Weight Change, Body | Obesity; Endocrine

Turkey
Grupo Español de Linfomas y Transplante Autólogo...

Recruiting

BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant (BRESELIBET)

Hodgkin Lymphoma, Adult

Spain
Second Affiliated Hospital, School of Medicine,...

Recruiting

Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease

Type 2 Diabetes | Peripheral Vascular Disorder Due to Diabetes Mellitus

China
Xiangya Hospital of Central South University

Recruiting

Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients

Obesity

China
First Affiliated Hospital of Jinan University

Recruiting

Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus (LAMP)

Ischemic Stroke | Type 2 Diabetes Mellitus | Transient Ischemic Attack

China
University of Virginia
National Institutes of Health (NIH); American Diabetes Association

Recruiting

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) (ZQL007)

Type2 Diabetes

United States
Xiangya Hospital of Central South University

Recruiting

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

Obesity

China
University of Miami
Novo Nordisk A/S

Recruiting

Liraglutide Effects on Epicardial Fat Inflammatory Genes

Coronary Artery Disease | Type2 Diabetes

United States
Second Xiangya Hospital of Central South University

Recruiting

Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes

Type1 Diabetes Mellitus | Autoimmune Diabetes

China
Samsung Medical Center
Ministry of Health, Republic of Korea

Recruiting

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Relapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid Tumor

Korea, Republic of
Novo Nordisk A/S

Active, not recruiting

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

Obesity

United States, Belgium, Malaysia, Portugal, Russian Federation, Switzerland, India, Israel, Mexico
Novo Nordisk A/S

Enrolling by invitation

Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.

Obesity

Taiwan
Novo Nordisk A/S

Completed

A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy

Diabetes Mellitus, Type 2

Italy
University of Miami

Active, not recruiting

Liraglutide Effect in Atrial Fibrillation (LEAF)

Atrial Fibrillation

United States
Lindner Center of HOPE

Completed

Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)

Obesity | Bipolar Disorder

United States
Mayo Clinic
Novo Nordisk A/S

Active, not recruiting

Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

Obesity

United States
Cedars-Sinai Medical Center
Novo Nordisk A/S; The Cure Parkinson's Trust

Completed

Safety and Efficacy of Liraglutide in Parkinson's Disease

Parkinson Disease

United States
Milton S. Hershey Medical Center
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Opioid-Related Disorders | Opiate Substitution Treatment

United States
Hospital de Clinicas de Porto Alegre

Completed

The Use of Liraglutide in Brain Death

Brain Death

Brazil
University at Buffalo

Completed

Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes (1974)

Type 1 Diabetes

United States
Dasman Diabetes Institute

Completed

Obesity Treatment to Improve Diabetes (OTID)

Type 1 Diabetes

Kuwait
Centre Hospitalier Universitaire Dijon

Terminated

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism (LIRA-NAFLD/LIP)

Type 2 Diabetes

France
Boehringer Ingelheim

Completed

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

Diabetes Mellitus, Type 2

Denmark
Novo Nordisk A/S

Completed

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany

Search clinical trials for: Liraglutide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations